Business
Ventripoint Announces Sponsorship of the 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
(TheNewswire) Toronto, Ontario – The Newswire – April 25, 2023 - Ventripo...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Announces Sponsorship of the 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Toronto, Ontario – The Newswire –\nApril 25, 2023\n \n \n - Ventripoint Diagnostics Ltd.\n(\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \"), (TSXV:VPT\n \n \n )\n \n \n ;\n \n \n (\n \n \n OTCQB:VPTDF) is pleased to announce its sponsorship of the\n56th Annual Meeting of the Association for European Paediatric and\nCongenital Cardiology (AEPC) being held on April 26\n \n \n th\n \n \n -29\n \n \n th\n \n \n 2023 in\nDublin, Ireland.\n \n \n \n \n The AEPC is a network of specialists in the paediatric\nand congenital cardiology field who strive to promote the sharing of\ninformation and resources within the community. The AEPC is currently\none of the largest global associations in the cardiac field with over\n1,000 paediatric cardiologists. We are excited to be part of this\nhighly specialized group of people to demonstrate how our products\nenhance cardiac care.\n \n \n \n \n This year’s theme is “\n \n \n \n Building\nBridges of Collaboration Across Europe In Congenital Cardiac\nCare”\n \n \n \n .\n \n \n Ventripoint is very much part of this collaboration and is\nsponsoring an Industrial Symposium with PD Dr. med. Kai Thorsten Laser\nspeaking about “Multi-Modality Assessment of the RV in Paediatric\nHeart Disease”. In particular, he will speak about his use of the\nVMS+ and its importance in the management and care of patients. Dr.\nLaser is the Deputy Director and Senior Physician from the Department\nof Pediatric Cardiology and Congenital Heart Defects of Herz-und\nDiabeteszentrium North Rhine-Westfalia | HDZ.\n \n \n He\nis a leading cardiologist in the\n \n \n assessment of\ncongenital heart disease using 2D/3D imaging.\n \n \n Assessment of right ventricular (RV) function is a challenge,\nespecially in patients with congenital heart disease (CHD). Regular\nand accurate assessment of RV function is an integral part of\ndiagnosing, planning treatment, and follow-up in such patients.\n \n \n \n \n This year’s conference and symposium are particularly\nnotable for Ventripoint as we have transformed VMS+ into a product\nthat offer...